Nina Hobi

1.3k total citations · 1 hit paper
32 papers, 960 citations indexed

About

Nina Hobi is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Endocrine and Autonomic Systems. According to data from OpenAlex, Nina Hobi has authored 32 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 11 papers in Biomedical Engineering and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in Nina Hobi's work include Inhalation and Respiratory Drug Delivery (18 papers), 3D Printing in Biomedical Research (10 papers) and Neonatal Respiratory Health Research (9 papers). Nina Hobi is often cited by papers focused on Inhalation and Respiratory Drug Delivery (18 papers), 3D Printing in Biomedical Research (10 papers) and Neonatal Respiratory Health Research (9 papers). Nina Hobi collaborates with scholars based in Switzerland, Germany and Austria. Nina Hobi's co-authors include Olivier T. Guenat, Thomas Geiser, Nicole Schneider‐Daum, Claus‐Michael Lehr, Janick D. Stucki, Manfred Frick, Hanno Huwer, Thomas Haller, Ralph A. Schmid and Paul Dietl and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Nina Hobi

31 papers receiving 947 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane

2021 230 citations Janick D. Stucki, Nina Hobi et al. Communications Biology profile →

Peers

Countries citing papers authored by Nina Hobi

Since Specialization

Citations

This map shows the geographic impact of Nina Hobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Hobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Hobi more than expected).

Fields of papers citing papers by Nina Hobi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Hobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Hobi. The network helps show where Nina Hobi may publish in the future.

Co-authorship network of co-authors of Nina Hobi

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Hobi. A scholar is included among the top collaborators of Nina Hobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Hobi. Nina Hobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Panel discussions on the global regulatory acceptance and harmonisation of non-animal NAMs 2025 ·(unknown), Ellen Fritsche, Nina Hobi, Nicole Kleinstreuer, Robert Lee, (unknown), (unknown), Clive Roper, Carl Westmoreland, (unknown)	1
2	A next-generation system for smoke inhalation integrated with a breathing lung-on-chip to model human lung responses to cigarette exposure 2025 ·Scientific Reports ·Arunima Sengupta, Simone Schmid, (unknown), (unknown), (unknown), Andreas Hugi, (unknown), (unknown), (unknown), (unknown), Philippe Krebs, Janick D. Stucki, Vera van der Velpen, Jesús Pérez‐Gil, Tobias Krebs, Nina Hobi, Olivier T. Guenat	2
3	The Use of MPS in Three Rs and Regulatory Applications: Perspectives From Developers on Stakeholder Responsibilities 2025 ·Alternatives to Laboratory Animals ·Megan R. LaFollette, Szczepan W. Baran, J. Lowry Curley, Anne M. Dickinson, Trivia Frazier, Nina Hobi, Mao Lin Huang, Victoria Hutter, (unknown), (unknown), (unknown), Iris Müller, Xiaohua Qian, (unknown), William R. Thelin, Jelena Vukasinovic, (unknown), Clive Roper	0
4	A stretchable human lung‐on‐chip model of alveolar inflammation for evaluating anti‐inflammatory drug response 2024 ·Bioengineering & Translational Medicine ·(unknown), Lorenz Latta, (unknown), (unknown), Janick D. Stucki, Nina Hobi, Andreas Hugi, Paul Schumacher, Tobias Krebs, (unknown), (unknown), (unknown), (unknown), Franziska Lautenschläger, Brigitta Loretz, Alberto Hidalgo, Nicole Schneider‐Daum, Claus‐Michael Lehr	5
5	A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip 2023 ·Frontiers in Pharmacology ·Arunima Sengupta, (unknown), Mohammad Jamshidi, (unknown), (unknown), (unknown), Andreas Hugi, A. Stucki, Patrick Dorn, Thomas M. Marti, (unknown), Janick D. Stucki, Tobias Krebs, Nina Hobi, Olivier T. Guenat	25
6	A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System 2022 ·SHILAP Revista de lepidopterología ·Arunima Sengupta, Nuria Roldán, Mirjam Kiener, Laurène Froment, (unknown), (unknown), (unknown), (unknown), Tobias May, (unknown), Nicole Schneider‐Daum, Claus‐Michael Lehr, (unknown), Thomas Geiser, Thomas M. Marti, Janick D. Stucki, Nina Hobi, Olivier T. Guenat	40
7	Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19 2021 ·Frontiers in Medicine ·Mirjam Kiener, Nuria Roldán, Carlos Machahua, Arunima Sengupta, Thomas Geiser, Olivier T. Guenat, Manuela Funke-Chambour, Nina Hobi, Marianna Kruithof‐de Julio	32
8	Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane breakdown → 2021 ·Communications Biology ·(unknown), (unknown), (unknown), (unknown), Janick D. Stucki, Nina Hobi, Nicole Schneider‐Daum, Claus‐Michael Lehr, Hanno Huwer, Thomas Geiser, Ralph A. Schmid, Olivier T. Guenat	230
9	Modeling idiopathic pulmonary fibrosis on a lung-on-chip 2021 ·(unknown), Nuria Roldán, Mirjam Kiener, Janick D. Stucki, Patrick Dorn, Thomas M. Marti, Thomas Geiser, (unknown), Nina Hobi	2
10	Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls 2020 ·Respiratory Research ·(unknown), (unknown), (unknown), Nina Hobi, (unknown), Cédric Simillion, (unknown), (unknown), Lars Knudsen, Thomas Geiser, Manuela Funke-Chambour	33
11	Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 2018 ·Neoplasia ·(unknown), Yanyun Gao, (unknown), Nina Hobi, Sabina Berezowska, (unknown), Laurène Froment, Stefan Weis, Ren‐Wang Peng, Rémy Bruggmann, Primo Schär, (unknown), (unknown), Patrick Dorn, Gregor J. Kocher, Carsten Riether, Adrian F. Ochsenbein, Ralph A. Schmid, Thomas M. Marti	46
12	Medium throughput breathing human primary cell alveolus-on-chip model 2018 ·Scientific Reports ·Janick D. Stucki, Nina Hobi, (unknown), A. Stucki, Nicole Schneider‐Daum, Claus‐Michael Lehr, Hanno Huwer, Manfred Frick, Manuela Funke-Chambour, Thomas Geiser, Olivier T. Guenat	126
13	Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro 2018 ·Angiogenesis ·(unknown), Colette A. Bichsel, Nina Hobi, Manuela Funke, Thomas M. Marti, Ralph A. Schmid, Olivier T. Guenat, Thomas Geiser	40
14	Lung alveoli array-on-chip with a bioartificial membrane 2017 ·Toxicology Letters ·(unknown), (unknown), Janick D. Stucki, Nina Hobi, Nicole Schneider‐Daum, Claus‐Michael Lehr, Hanno Huwer, Ralph A. Schmid, Olivier T. Guenat	1
15	A small key unlocks a heavy door: The essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Nina Hobi, Michael Giolai, Bárbara Olmeda, Pika Miklavc, Edward Felder, Paul Walther, Paul Dietl, Manfred Frick, Jesús Pérez‐Gil, Thomas Haller	41
16	A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores 2015 ·Cell Calcium ·Giorgio Fois, Nina Hobi, Edward Felder, Andreas Ziegler, Pika Miklavc, Paul Walther, Peter Radermacher, Thomas Haller, Paul Dietl	44
17	Physiological variables affecting surface film formation by native lamellar body-like pulmonary surfactant particles 2014 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Nina Hobi, (unknown), (unknown), Andrea Ravasio, Jesús Pérez‐Gil, Thomas Haller	28
18	Nontoxic impact of PEG-coated gold nanospheres on functional pulmonary surfactant-secreting alveolar type II cells 2013 ·Nanotoxicology ·(unknown), Thomas Haller, Nina Hobi, Edward Felder, Isabel Pastoriza‐Santos, Jesús Pérez‐Gil	23
19	Actin coating and compression of fused secretory vesicles are essential for surfactant secretion: a role for Rho, formins and myosin II 2012 ·Journal of Cell Science ·Pika Miklavc, (unknown), Nina Hobi, Oliver H. Wittekindt, Paul Dietl, Christine Kranz, Manfred Frick	59
20	Effects of Perfluorocarbons on surfactant exocytosis and membrane properties in isolated alveolar type II cells 2010 ·Respiratory Research ·(unknown), (unknown), Nina Hobi, Andrea Ravasio, Thomas Haller, Mario Rüdiger	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact